Browse > Article

Expression of VEGF, p53, Apaf-1 and Caspase-9 in Head and Neck Squamous Cell Carcinoma  

Lee, Sung Hak (Department of pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
Kang, Yeo Ju (Department of pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
Jo, Ui Ju (Department of pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
Lee, Youn Soo (Department of pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
Kang, Chang Suk (Department of pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine)
Publication Information
Korean Journal of Head & Neck Oncology / v.28, no.2, 2012 , pp. 107-113 More about this Journal
Keywords
Vascular endothelial growth factor;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Johnstone S, Logan RM. The role of vascular endothelial growth factor(VEGF) in oral dysplasia and oral squamous cell carcinoma. Oral Oncol. 2006;42:337-342.   DOI   ScienceOn
2 Kyzas PA, Cunha IW, Ioannidis JP. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: A meta-analysis. Clin Cancer Res. 2005;11:1434-1440.   DOI   ScienceOn
3 Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, et al. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127:780-785.
4 Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol. 2002;55:98-104.   DOI
5 Tabor MP, van Houten VM, Kummer JA, Vosjan MJ, Vlasblom R, Snow GB, et al. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer. 2002;33:168-177.   DOI   ScienceOn
6 Dijkema IM, Struikmans H, Dullens HF, Kal HB, van der Tweel I, Battermann JJ. Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients. Oral Oncol. 2000;36:54-60.   DOI   ScienceOn
7 Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Molecular Cell. 1998;1:949-957.   DOI   ScienceOn
8 Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.   DOI   ScienceOn
9 Zlobec I, Minoo P, Baker K, Haegert D, Khetani K, Tornillo L, et al. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colo rectal cancer. European Journal of Cancer. 2007;43:1101-1107.   DOI   ScienceOn
10 Papay J, Krenacs T, Moldvay J, Stelkovics E, Furak J, Molnar B, et al. Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach. Appl lmmunohistochem Mol Morphol. 2007;15:19-30.   DOI   ScienceOn
11 Strater J, Herter I, Merkel G, Hinz U, Weitz J, Moller P. Expression and prognostic significance of APAF-1, caspase-8 and caspase-9 in stage II/III colon carcinoma: Caspase-8 and caspase-9 is associated with poor prognosis. Int J Cancer. 2010;127:873-880.
12 Wang P, Shi T, Ma D. Cloning of a novel human caspase-9 splice variant containing only the CARD domain. Life Sci. 2006;79:934-940.   DOI   ScienceOn
13 Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM. A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev. 2010;19:574-587   DOI   ScienceOn
14 Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326(Pt 1):1-16.
15 Kuwahara D, Tsutsumi K, Kobayashi T, Hasunuma T, Nishioka K. Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells. Cancer Lett. 2000;148:65-71.   DOI   ScienceOn
16 Sarkis SA, Abdullah BH, Abdul Majeed BA, Talabani NG. Immunohistochemical expression of epidermal growth factor receptor(EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis. Head Neck Oncol. 2010;2:13.   DOI   ScienceOn
17 Zbaren P, Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg. 1987;113:762-764.   DOI   ScienceOn
18 Oh JE, Kim MS, Kang MR, Kim YR, Kim HS, Yoo NJ, et al. Expression of apoptosis-related proteins caspase-6, caspase-9, FLIP and BNIP 3 in oesophageal squamous cell carcinomas. Pathology. 2010;42:492-493.   DOI   ScienceOn
19 Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science. 1999;284:156-159.   DOI   ScienceOn
20 Kaomongkolgit R, Chaisomboon N, Pavasant P. Apoptotic effect of alpha-mangostin on head and neck squamous carcinoma cells. Arch Oral Biol. 2011;56:483-490.   DOI   ScienceOn
21 Koh JY, Cho NP, Kong G, Lee JD, Yoon K. p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: Correlation with apoptosis. Br J Cancer. 1998;78:354-359.   DOI   ScienceOn
22 Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.   DOI   ScienceOn
23 Kowalski LP, Medina JE. Nodal metastases: Predictive factors. Otolaryngol Clin North Am. 1998;31:621-637.   DOI   ScienceOn
24 Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.   DOI   ScienceOn
25 Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW 2nd, Duran WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-112 and nitric oxide. AmJ Physiol Heart Circ Physiol. 2003;284:H92-H100.
26 Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49-53.   DOI
27 Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, et al. VEGF prevents apoptosis of human microvascular endo-thelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res. 1999;247:495-504.   DOI   ScienceOn
28 Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litvin S, Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res. 1999;5:775-782.
29 Danial NN, Korsmeyer SJ. Cell death critical control points. Cell. 2004;116:205-219.   DOI   ScienceOn